White label ELPA - ClinicalTrials.eu

Study of Olaparib, Durvalumab and UV1 combination as maintenance treatment for patients with recurrent ovarian cancer who do not have BRCA mutations

Not recruiting

2 1 1 1
Investigated diseases:
- Ovarian cancer
Investigated drugs:
+3
Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Not recruiting

3 1 1
Investigated diseases:
Investigated drugs:
- Rucaparib
+5
Study on the Long-Term Safety and Effectiveness of Glepaglutide for Patients with Short Bowel Syndrome

Not recruiting

3 1
Investigated diseases:
- Short-bowel syndrome
Investigated drugs:
- Glepaglutide
Study of Vericiguat to improve physical function in patients with Post-COVID-19 syndrome with or without chronic fatigue syndrome

Not recruiting

2 1
Investigated diseases:
- Post-acute COVID-19 syndrome
Investigated drugs:
- Vericiguat
Study on the Safety and Effectiveness of Pegcetacoplan for Patients with Post-Transplant Recurrence of C3 Glomerulopathy or Immune Complex Membranoproliferative Nephritis

Not recruiting

2 1 1 1
Investigated diseases:
- C3 glomerulopathy
- Glomerulonephritis membranoproliferative
Investigated drugs:
- Pegcetacoplan
Study of EOS884448, Dostarlimab, and Inupadenant for Patients with Advanced Solid Tumors

Not recruiting

1 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Study on the Effectiveness and Safety of Barzolvolimab for Patients with Chronic Inducible Urticaria

Not recruiting

2 1 1
Investigated diseases:
- Cold urticaria
Investigated drugs:
- Barzolvolimab
+1
Study of organ preservation using chemoradiotherapy and transanal surgery compared to standard surgery in patients with early rectal cancer (STAR-TREC trial)

Not recruiting

4 1 1 1
Investigated diseases:
- Colorectal cancer
Study on Ephedrine and Rocuronium for Faster Muscle Relaxation in Patients Aged 80 and Above Undergoing Elective Surgery

Not recruiting

3 1 1
Investigated drugs:
- Ephedrine Hydrochloride
- Saline
Study on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma

Not recruiting

2 1 1 1
Investigated diseases:
- Neuroblastoma
Investigated drugs:
- Cyclophosphamide
- Dinutuximab Beta

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies